About 40–50% of Asian patients with NSCLC harbor epidermal growth factor receptor (EGFR) mutations, and distant metastases are observed in nearly 40% of these patients at initial diagnosis (1). This evidence concerns the gene EGFR and non-small cell lung carcinoma.